Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

In this article we will help you to know more about the infusion therapy, about its process, precautions to be taken care ...

Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents are frequently observed.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

A RECENT study has highlighted key biological and clinical factors linked to resistance to biologic therapies in patients ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

It is the first clinical trial to evaluate a biologic therapy to prevent serious adverse ... Crohn’s disease and plaque psoriasis, could offer better protection to APS pregnancies than blood ...